Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 414 followers
Latest posts
Last updated about 14 hours ago
Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
about 14 hours ago
After Jenny Pearson’s daughter Elise first had a seizure at 16 months...
Daiichi unit American Regent recalls 3 epinephrine batches on particulate, leakage concerns
about 15 hours ago
Daiichi Sankyo subsidiary American Regent is launching a recall of three lots...
The people who stayed with the problem
about 16 hours ago
In this week’s episode of “The Top Line,” we look at the...
UCB’s Bimzelx comes from out of the blue to claim August’s top pharma ad spending spot
about 17 hours ago
Move over AbbVie and Johnson & Johnson, we have a new and...
A year on from Big Pharma’s pull-back from the UK, has anything changed?
about 17 hours ago
September 2025 marked a low point for relations between the U.K. government...
Fierce Pharma Asia—Roche, GSK, Novartis billion-dollar deals; More MFN sign-ups; Akeso’s OS win
about 17 hours ago
GSK, Roche and Novartis continued their dealmaking spree with Asian companies. Three...
Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers
1 day ago
Following a string of customer complaints, a Form 483 and a recall...
Novartis puts MS advocacy on the podium through social media partnership with British Olympian
1 day ago
The social media collaboration ties into Novartis' "you know your MS best"...
FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod
1 day ago
Two votes of confidence from leaders at the FDA’s Office of Clinical...
CMI boosts medical affairs capabilities with new specialty communications unit
1 day ago
The new business unit is centered on four core capabilities, which includes...
From Question to Action: Rethinking Pharma Engagement in the AI Era
1 day ago
As AI reshapes health discovery, GoodRx is helping pharma turn consumer and...
Akeso, Summit’s ivonescimab extends lives in Keytruda head-to-head trial. What now?
1 day ago
About two years ago, a head-to-head progression-free survival win made Akeso and...